[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf

上传人:任我行 文档编号:31320 上传时间:2022-06-24 发布时间:2021-10-21 格式:PDF 页数:8 大小:860.91KB
下载 相关 举报
[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf_第1页
第1页 / 共8页
[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf_第2页
第2页 / 共8页
[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf_第3页
第3页 / 共8页
[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf_第4页
第4页 / 共8页
[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf_第5页
第5页 / 共8页
点击查看更多>>
资源描述

1、CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Compensation Programs for Potential COVID-19 Vaccine Injuries Updated October 20, 2021 More than 200 million Americans have received one or more doses of a Coronavirus Disease 2019 (COVID-19) vaccine, alo

2、ng with billions of people worldwide. The Food and Drug Administrations (FDAs) emergency use authorizations for the Pfizer-BioNTech, Moderna, and Johnson & Johnson COVID-19 vaccines were based on months-long clinical trials (including safety monitoring) of each vaccine, involving tens of thousands o

3、f participants. These trials did not identify any safety concerns that would preclude such authorization. (The Pfizer-BioNTech COVID-19 vaccine subsequently received full approval from FDA.) Post-authorization, the COVID-19 vaccines have been subject to safety monitoring requirements by FDA and the

4、Centers for Disease Control and Prevention (CDC) to detect long-term or rare adverse health events. (For more information, see this CRS report.) The most common side effects of COVID-19 vaccines are mildsuch as local pain around the injection side, tiredness, or feverand usually resolve within a few

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告